(Q40834816)

English

Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

type-1 diabetes

0 references

5

object named as

Louis Gooren

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

4

object named as

Gheorghe Doros

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

author name string

Farid Saad

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Aksam Yassin

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Yousef Almehmadi

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

publication date

15 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

164-168

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Prevalence of low testosterone and predisposing risk factors in men with type 1 diabetes mellitus: findings from the DCCT/EDIC

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Obesity and age as dominant correlates of low testosterone in men irrespective of diabetes status.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Testosterone concentration in young patients with diabetes

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Age, insulin requirements, waist circumference, and triglycerides predict hypogonadotropic hypogonadism in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: an observational study.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Effects of long-term testosterone therapy on patients with "diabesity": results of observational studies of pooled analyses in obese hypogonadal men with type 2 diabetes

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome.

1 reference

https://api.crossref.org/works/10.3109%2F13685538.2015.1034687

21 January 2018

Identifiers

10.3109/13685538.2015.1034687

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

release_hxso5q4mvngk5i5ioi3xsfcoha

1 reference

https://api.fatcat.wiki/v0/release/hxso5q4mvngk5i5ioi3xsfcoha

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40834816&oldid=1908358780"